(VIANEWS) – EUROFINS SCIENT. (ERF.PA) is among this list of stock assets with the highest dividend rate and return on equity on the Healthcare sector.
| Financial Asset | Price | Forward Dividend Yield | Return on Equity |
|---|---|---|---|
| EUROFINS SCIENT. (ERF.PA) | €59.08 | 1.82% | 6.16% |
| TUBIZE-FIN (TUB.BR) | €104.20 | 0.93% | 4.97% |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. EUROFINS SCIENT. (ERF.PA)
1.82% Forward Dividend Yield and 6.16% Return On Equity
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Earnings Per Share
As for profitability, EUROFINS SCIENT. has a trailing twelve months EPS of €1.57.
PE Ratio
EUROFINS SCIENT. has a trailing twelve months price to earnings ratio of 37.63. Meaning, the purchaser of the share is investing €37.63 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1.82%.
Yearly Top and Bottom Value
EUROFINS SCIENT.’s stock is valued at €59.08 at 02:30 EST, under its 52-week high of €63.74 and way above its 52-week low of €44.83.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROFINS SCIENT.’s stock is considered to be overbought (>=80).
More news about EUROFINS SCIENT..
2. TUBIZE-FIN (TUB.BR)
0.93% Forward Dividend Yield and 4.97% Return On Equity
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. The company was incorporated in 1928 and is based in Brussels, Belgium.
Earnings Per Share
As for profitability, TUBIZE-FIN has a trailing twelve months EPS of €1.99.
PE Ratio
TUBIZE-FIN has a trailing twelve months price to earnings ratio of 52.36. Meaning, the purchaser of the share is investing €52.36 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.97%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 30, 2024, the estimated forward annual dividend rate is 0.97 and the estimated forward annual dividend yield is 0.93%.
Moving Average
TUBIZE-FIN’s worth is above its 50-day moving average of €95.12 and way above its 200-day moving average of €78.48.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TUBIZE-FIN’s stock is considered to be oversold (<=20).
More news about TUBIZE-FIN.
